H1N1 Hemagglutinin 1 Polyclonal Antibody, Biotin Conjugated
Product Specifications
Background
Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species jumping ability.Influenza A Virus [A/California/04/2009 (H1N1) ]
Synonyms
HA; HA1; Hemagglutinin; Influenza A Virus [A/California/04/2009H1N1].
Host
Rabbit
Cross Reactivity
Virus
Immunogen
1-100/566
Target
H1N1 Hemagglutinin 1
Clonality
Polyclonal
Isotype
IgG
Conjugation
Biotin
Source
KLH conjugated synthetic peptide derived from Influenza A Virus Hemagglutinin
Applications
ELISA
Purification
Purified by Protein A.
Concentration
1µg/µl
Dilution
ELISA (1:500-1000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C for 12 months.
Product Datasheet
https://www.biossantibodies.com/datasheets/bs-2001R-Biotin
Cross Reactivity Details
Influenza A virus H1N1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
